UnitedHealth Group (NYSE:UNH) will post its quarterly earnings results before the market opens on Tuesday, October 16th. Analysts expect UnitedHealth Group to post earnings of $3.30 per share for the quarter. UnitedHealth Group has set its FY18 guidance at $12.50-12.75 EPS.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 17th. The healthcare conglomerate reported $3.14 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.04 by $0.10. The company had revenue of $56.09 billion for the quarter, compared to the consensus estimate of $56.10 billion. UnitedHealth Group had a net margin of 5.55% and a return on equity of 22.79%. The firm’s revenue was up 12.1% compared to the same quarter last year. During the same quarter last year, the firm posted $2.46 earnings per share. On average, analysts expect UnitedHealth Group to post $13 EPS for the current fiscal year and $14 EPS for the next fiscal year.

UNH opened at $259.61 on Friday. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 0.63. The company has a market capitalization of $256.06 billion, a P/E ratio of 25.78, a price-to-earnings-growth ratio of 1.58 and a beta of 0.73. UnitedHealth Group has a 12-month low of $186.00 and a 12-month high of $272.07.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 18th. Investors of record on Friday, September 7th were issued a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.39%. The ex-dividend date of this dividend was Thursday, September 6th. UnitedHealth Group’s payout ratio is 35.75%.

A number of equities analysts recently issued reports on the stock. Barclays raised their price objective on shares of UnitedHealth Group from $265.00 to $280.00 and gave the stock an “overweight” rating in a report on Friday. Jefferies Financial Group raised their price objective on shares of UnitedHealth Group from $270.00 to $311.00 and gave the stock a “buy” rating in a report on Wednesday, October 3rd. ValuEngine raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Tuesday, October 2nd. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $299.00 price target on the stock in a report on Tuesday, September 25th. Finally, Raymond James lifted their price target on shares of UnitedHealth Group from $285.00 to $304.00 and gave the company a “strong-buy” rating in a report on Monday, September 24th. One research analyst has rated the stock with a hold rating, twenty-two have given a buy rating and one has given a strong buy rating to the stock. UnitedHealth Group presently has an average rating of “Buy” and a consensus target price of $279.26.

In other news, Director Kenneth Irwin Shine sold 177 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, July 18th. The shares were sold at an average price of $255.72, for a total transaction of $45,262.44. Following the sale, the director now owns 29,053 shares in the company, valued at $7,429,433.16. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Steven H. Nelson sold 26,033 shares of UnitedHealth Group stock in a transaction that occurred on Friday, September 7th. The shares were sold at an average price of $270.65, for a total transaction of $7,045,831.45. The disclosure for this sale can be found here. Insiders have sold 94,745 shares of company stock worth $24,995,290 in the last ninety days. Insiders own 0.87% of the company’s stock.

A hedge fund recently raised its stake in UnitedHealth Group stock. Argent Trust Co grew its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 8.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,911 shares of the healthcare conglomerate’s stock after buying an additional 1,061 shares during the period. UnitedHealth Group accounts for about 0.8% of Argent Trust Co’s investment portfolio, making the stock its 15th largest position. Argent Trust Co’s holdings in UnitedHealth Group were worth $3,066,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 85.35% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Further Reading: Understanding Price to Earnings Ratio (PE)

Earnings History for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.